Whilst there is a lack of data to directly link TCA cycle dysfunction in NAFLD with PHD inhibition and HIF stabilisation, there are limited data from rat models demonstrating altered HIF-1α mRNA and protein levels in steatotic whole liver [72]. This evidence concerns the gene PDC and metabolic dysfunction-associated steatotic liver disease.